Health score, competitive moat, risk signals, and key metrics at a glance.
Competitive analysis based on 36 quarters of fundamental data
Operating margins are under pressure, averaging 5.3%. The business may lack pricing power or face rising costs.'
Consistently high ROE averaging 41.7% suggests a durable competitive advantage and efficient capital allocation.
Data-driven red flags and warnings across 36 quarters
The company posted negative operating margins in recent quarters — core operations are unprofitable.
FCF/Net Income has dropped below 0.7x in 3 quarters — monitor for earnings quality deterioration.
D/E ratio is 0.1 — conservative capital structure with low financial risk.
Revenue has softened, declining in 4 quarters. Monitor for further erosion.
FCF turned negative in 2 of the last 8 quarters — occasional cash consumption.
Shares decreased 17.9% — net buybacks are reducing shares outstanding and boosting per-share value.
as of October 2025
Revenue, EBITDA, operating income, net income, EPS, and shares
Gross, EBITDA, operating, and net margin trends
P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield
Total assets, cash, debt, book value, and leverage
Operating cash flow, free cash flow, FCF margin, and earnings quality
6 of the last 8 quarters generated positive FCF. The company generally funds itself but has occasional cash consumption quarters.
Revenue has been flat or declining over recent quarters, which may indicate eroding demand or competitive pressure.
